CelliXio Overview
- Year Founded
-
2025
- Status
-
Out of Business
- Latest Deal Type
-
Liquidation
CelliXio General Information
Description
Operator of fluidic stress analysis tools intended for biopharmaceutical manufacturing processes. The company offers patented microfluidic-based analyzers that characterize cellular responses to shear stress, combining computerized flow modeling, inflow experimentation without fluorescent markers, and AI driven classification of cell viability, apoptosis, and necrosis, enabling biotech and medical device manufacturers to optimize equipment design, improve bioproduction yields, enhance process robustness, and reduce downstream processing costs.
Contact Information
Website
www.cellixio.comCorporate Office
- 5 rue Gaston Berger
- 69100 Villeurbanne
- France
Corporate Office
- 5 rue Gaston Berger
- 69100 Villeurbanne
- France
CelliXio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Bankruptcy: Liquidation | 23-Dec-2025 | Completed | Bankruptcy: Liquidation | |||
| 1. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue |
CelliXio FAQs
-
When was CelliXio founded?
CelliXio was founded in 2025.
-
Where is CelliXio headquartered?
CelliXio is headquartered in Villeurbanne, France.
-
What industry is CelliXio in?
CelliXio’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is CelliXio a private or public company?
CelliXio is a Private company.
-
What is CelliXio’s current revenue?
The current revenue for CelliXio is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process